Mismatched Tech And Demand Behind Korea’s Slow Pharma AI Progress
'Trial And Error' Process
The new head of South Korea’s AI Drug Development Support Center talks about the country’s activities and market trends in the field, why the otherwise tech-savvy country is still lagging and what is needed to boost collaboration and the availability of big data.
